| 000 | 01256 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516083237.0 | ||
| 264 | 0 | _c20120726 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a1866-0452 | ||
| 024 | 7 |
_a10.3238/arztebl.2012.0117 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aUjeyl, Mariam | |
| 245 | 0 | 0 |
_aNew drugs: evidence relating to their therapeutic value after introduction to the market. _h[electronic resource] |
| 260 |
_bDeutsches Arzteblatt international _cFeb 2012 |
||
| 300 |
_a117-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 |
_aDrug Therapy _xstatistics & numerical data |
| 650 | 0 | 4 | _aEuropean Union |
| 650 | 0 | 4 |
_aEvidence-Based Medicine _xstatistics & numerical data |
| 650 | 0 | 4 |
_aMarketing _xstatistics & numerical data |
| 650 | 0 | 4 |
_aOutcome Assessment, Health Care _xstatistics & numerical data |
| 650 | 0 | 4 |
_aProduct Surveillance, Postmarketing _xstatistics & numerical data |
| 700 | 1 | _aSchlegel, Claudia | |
| 700 | 1 | _aWalter, Siegbert | |
| 700 | 1 | _aGundert-Remy, Ursula | |
| 773 | 0 |
_tDeutsches Arzteblatt international _gvol. 109 _gno. 7 _gp. 117-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3238/arztebl.2012.0117 _zAvailable from publisher's website |
| 999 |
_c21632237 _d21632237 |
||